Evidence Synthesis
Gangapharm (GANGAPHARM) reported a quarterly Gross Margin of 53.91%, accelerating from 2.15%.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 5 Sept 2026, 03:55
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
Gangapharm (GANGAPHARM) reported a quarterly Gross Margin of 53.91%, accelerating from 2.15%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 53.91 % | 2.15 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 2.15 % | 3.59 | ▼ |
| REVENUE_GROWTH_YOY | 10.2 % | 103.3 | ▼ |
| PRICE_CHANGE_PERCENT | 0 % | — | - |
| DAILY_VOLUME | 8,000 shares | 0 | ▲ |
| CLOSE_PRICE | 12 INR | 12 | - |